BioAmber Company Profile (NYSE:BIOA)

About BioAmber

BioAmber logoBioAmber Inc. (BioAmber), formerly DNP Green Technology, Inc., is an industrial biotechnology company, which produces sustainable chemicals. The Company's technology platform combines industrial biotechnology and chemical catalysis to convert renewable feedstocks into sustainable chemicals that are replacements for petroleum-derived chemicals, which are used in a range of everyday products, including plastics, food additives and personal care products. Its geographical segments include Europe and North America. Its product pipeline includes the derivatives of bio-succinic acid, such as 1,4 Butanediol (1,4 BDO) and tetrahydrofuran (THF), and succinic acid-based polyesters, and C6 building block chemicals, such as adipic acid, caprolactam and hexamethylenediamine (HMDA). Its products are used in various applications, including polyurethanes, resins and coatings, de-icing and coolant solutions, fine chemicals, lubricants, carpets, engineering plastics and artificial leather products.

Industry, Sector and Symbol:
  • Sector: Basic Materials
  • Industry: Chemicals - Major Diversified
  • Sub-Industry: N/A
  • Exchange: NYSE
  • Symbol: BIOA
  • CUSIP:
Key Metrics:
  • Previous Close: $3.41
  • 50 Day Moving Average: $4.45
  • 200 Day Moving Average: $4.41
  • 52-Week Range: $2.86 - $6.50
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -7.75
  • P/E Growth: 0.00
  • Market Cap: $98.33M
  • Outstanding Shares: 28,836,000
  • Beta: 2.69
Profitability:
  • Net Margins: -227.35%
  • Return on Equity: -63.08%
  • Return on Assets: -21.80%
Debt:
  • Debt-to-Equity Ratio: 0.58%
  • Current Ratio: 0.80%
  • Quick Ratio: 0.71%
Additional Links:
Companies Related to BioAmber:

Analyst Ratings

Consensus Ratings for BioAmber (NYSE:BIOA) (?)
Ratings Breakdown: 3 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $11.25 (229.91% upside)

Analysts' Ratings History for BioAmber (NYSE:BIOA)
Show:
DateFirmActionRatingPrice TargetDetails
1/30/2017AltaCorp CapitalReiterated RatingOutperformView Rating Details
8/7/2016Canaccord GenuityReiterated RatingBuy$5.50View Rating Details
3/28/2016Credit Suisse GroupBoost Price TargetOutperform$15.00 -> $17.00View Rating Details
1/5/2016HC WainwrightReiterated RatingBuy$18.00View Rating Details
1/5/2016Rodman & RenshawInitiated CoverageBuy$18.00View Rating Details
(Data available from 2/23/2015 forward)

Earnings

Earnings History for BioAmber (NYSE:BIOA)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/13/2017        
5/3/2016Q1($0.24)($0.39)ViewN/AView Earnings Details
3/14/2016Q415($0.35)($0.40)$1.11 millionViewN/AView Earnings Details
11/4/2015Q315($0.41)($0.27)$2.30 millionViewN/AView Earnings Details
8/4/2015Q215($0.50)($0.58)ViewN/AView Earnings Details
3/12/2015Q414($0.39)($0.20)ViewN/AView Earnings Details
11/6/2014($0.40)($0.41)ViewN/AView Earnings Details
8/7/2014($0.44)($0.40)ViewN/AView Earnings Details
5/8/2014Q1($0.46)($0.45)ViewListenView Earnings Details
3/13/2014($0.36)($0.45)ViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for BioAmber (NYSE:BIOA)
Current Year EPS Consensus Estimate: $-0.71 EPS
Next Year EPS Consensus Estimate: $-0.44 EPS

Dividends

Dividend History for BioAmber (NYSE:BIOA)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for BioAmber (NYSE:BIOA)
Insider Ownership Percentage: 7.07%
Institutional Ownership Percentage: 35.19%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/9/2016George Frederick John GosbeeDirectorBuy25,000$3.87$96,750.00View SEC Filing  
11/8/2016Kurt W BrinerDirectorBuy10,000$3.84$38,400.00View SEC Filing  
5/24/2016Kurt W BrinerDirectorBuy1,000$3.69$3,690.00View SEC Filing  
5/23/2016Kurt W BrinerDirectorBuy21,015$3.61$75,864.15View SEC Filing  
5/11/2016Jean-Francois HucCEOBuy10,000$3.22$32,200.00View SEC Filing  
5/9/2016Kenneth W WallDirectorBuy13,227$3.11$41,135.97View SEC Filing  
5/6/2016Michael A HartmannEVPBuy3,000$3.44$10,320.00View SEC Filing  
12/3/2015Jean-Francois HucCEOSell27,278$8.11$221,224.58View SEC Filing  
12/3/2015Michael A. HartmannEVPSell21,477$8.11$174,178.47View SEC Filing  
8/14/2015Michael A HartmannEVPBuy1,500$6.75$10,125.00View SEC Filing  
8/11/2015Jean-Francois HucCEOBuy4,000$6.18$24,720.00View SEC Filing  
8/10/2015Raymond J LandDirectorBuy1,500$6.71$10,065.00View SEC Filing  
5/6/2015Jean-Francois HucCEOBuy8,800$9.00$79,200.00View SEC Filing  
5/6/2015Kurt W BrinerDirectorBuy10,000$9.00$90,000.00View SEC Filing  
5/6/2015Michael A HartmannEVPBuy1,100$9.00$9,900.00View SEC Filing  
12/11/2014Kenneth W WallDirectorBuy3,000$9.20$27,600.00View SEC Filing  
12/10/2014Kenneth W WallDirectorBuy5,000$9.30$46,500.00View SEC Filing  
11/10/2014Kurt W BrinerDirectorBuy15,000$9.35$140,250.00View SEC Filing  
9/9/2014Kurt W BrinerDirectorBuy5,000$12.00$60,000.00View SEC Filing  
8/25/2014Kurt W BrinerDirectorBuy14,250$11.50$163,875.00View SEC Filing  
8/11/2014Kurt W BrinerDirectorBuy2,980$11.45$34,121.00View SEC Filing  
7/16/2014Jean-Francois HucCEOBuy4,000$12.00$48,000.00View SEC Filing  
7/16/2014Michael A HartmannEVPBuy3,000$12.00$36,000.00View SEC Filing  
5/12/2014Andrew P AshworthCFOBuy3,000$10.00$30,000.00View SEC Filing  
5/12/2014Michael A HartmannEVPBuy2,500$10.05$25,125.00View SEC Filing  
11/14/2013Kurt W BrinerDirectorBuy7,200$6.95$50,040.00View SEC Filing  
9/3/2013Michael A HartmannEVPBuy2,000$4.63$9,260.00View SEC Filing  
8/29/2013Jean-Francois HucCEOBuy5,000$4.25$21,250.00View SEC Filing  
8/15/2013Kurt W BrinerDirectorBuy13,000$5.49$71,370.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for BioAmber (NYSE:BIOA)
DateHeadline
News IconInvestor Study: Looking at the Levels for BioAmber Inc (BIOA) - Baxter Review (NYSE:BIOA)
baxternewsreview.com - February 23 at 8:23 PM
News IconResearch Analyst Places These Stocks on BioAmber Inc. (NYSE:BIOA) Amyris, Inc. (NASDAQ:AMRS) - Rives Journal (NYSE:BIOA)
rivesjournal.com - February 23 at 3:22 PM
News IconBioAmber CEO steps down, current COO named president (NYSE:BIOA)
www.worldofchemicals.com - February 22 at 9:02 PM
streetinsider.com logoForm 8-K BioAmber Inc. For: Feb 17 (NYSE:BIOA)
www.streetinsider.com - February 22 at 9:02 PM
News IconBioAmber Announces Sudden Change At The Helm (NYSE:BIOA)
blackburnnews.com - February 22 at 9:02 PM
marketexclusive.com logoBIOAMBER INC. (NYSE:BIOA) Files An 8-K Entry into a Material Definitive Agreement (NYSE:BIOA)
marketexclusive.com - February 22 at 9:02 PM
News IconBioAmber CEO Steps Down - Pharmaceutical Executive (press release) (registration) (blog) (NYSE:BIOA)
www.pharmexec.com - February 22 at 4:00 PM
News IconTechnical Trading: Focus on Shares of BioAmber Inc (BIOA) - Davidson Register (NYSE:BIOA)
davidsonregister.com - February 21 at 3:24 PM
finance.yahoo.com logo3:58 am BioAmber Pres/CEO resigns; names current COO as President (NYSE:BIOA)
finance.yahoo.com - February 21 at 10:41 AM
biz.yahoo.com logoBIOAMBER INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Principal Office (NYSE:BIOA)
biz.yahoo.com - February 21 at 10:41 AM
prnewswire.com logoBioAmber CEO steps down, current COO Fabrice Orecchioni named President - PR Newswire (press release) (NYSE:BIOA)
www.prnewswire.com - February 20 at 3:41 PM
finance.yahoo.com logoBioAmber CEO steps down, current COO Fabrice Orecchioni named President (NYSE:BIOA)
finance.yahoo.com - February 20 at 3:41 PM
News IconAre Insiders Pocketing Their Own Shares of BioAmber Inc. (NYSE:BIOA)? - Winfield Review (NYSE:BIOA)
winfieldreview.com - February 20 at 10:54 AM
News IconShares in Review: Levels in Focus for BioAmber Inc. (NYSE:BIOA) - Providence Standard (NYSE:BIOA)
providencestandard.com - February 18 at 8:00 AM
News IconTrading Corner: Eye on Technical Levels for Bioamber Inc. (BIOA) - Benton Bulletin (NYSE:BIOA)
bentonbulletin.com - February 18 at 8:00 AM
News IconGlobal Green and Bio Solvents Sales Industry Forecast to 2021 with Key Companies Profile, Supply, Demand, Cost Structure, and SWOT Analysis (NYSE:BIOA)
empowerednews.net - February 17 at 10:37 AM
sbwire.com logoSynthetic Leathers Market: Global Industry Analysis and Forecast 2016 - 2024 (NYSE:BIOA)
www.sbwire.com - February 17 at 10:37 AM
finanznachrichten.de logoSynthetic Biology: Global Markets - Research and Markets (NYSE:BIOA)
www.finanznachrichten.de - February 16 at 3:58 PM
finance.yahoo.com logoGlobal Adipic Acid Industry (NYSE:BIOA)
finance.yahoo.com - February 14 at 4:28 PM
openpr.com logoIncreasing demand for bio-based materials in various downstream industries is expected to boost the demand for Green & Bio-based Solvents Market (NYSE:BIOA)
www.openpr.com - February 11 at 3:56 PM
News IconStock Survey: Checking Levels for BioAmber Inc. (NYSE:BIOA) - Baxter Review (NYSE:BIOA)
baxternewsreview.com - February 10 at 8:25 PM
News IconWatching Technical Levels on Shares of Bioamber Inc. (BIOA) - Sherwood Daily (NYSE:BIOA)
sherwooddaily.com - February 10 at 3:24 PM
News IconChart Indicators in Focus for Bioamber Inc. (BIOA) - Rives Journal (NYSE:BIOA)
rivesjournal.com - February 10 at 2:08 AM
News IconChecking on the Charts for BioAmber Inc. (NYSE:BIOA) - Davidson Register (NYSE:BIOA)
davidsonregister.com - February 9 at 9:07 PM
prnewswire.com logoGlobal Bio-Alcohols Market Expected to Reach $11,574 Million by 2022 - Allied Market Research (NYSE:BIOA)
www.prnewswire.com - February 8 at 4:04 PM
newsmaker.com.au logoGreen & Bio-based Solvents Market Expected to Register High Revenue Growth Through 2021 (NYSE:BIOA)
www.newsmaker.com.au - February 8 at 2:55 AM
News IconGreen And Bio-based Solvents Market Size Worth $13.74 Billion By 2024: Grand View Research, Inc. (NYSE:BIOA)
www.abnewswire.com - February 7 at 4:52 PM
News IconMarket Scope: F-Score and Volatility Review for BioAmber Inc. (NYSE:BIOA) - Gilbert Daily (NYSE:BIOA)
gilbertdaily.com - February 1 at 4:08 PM
openpr.com logoGreen & Bio-based Solvents Market - Global Industry Analysis 2023 (NYSE:BIOA)
www.openpr.com - January 31 at 4:10 PM
News IconBioAmber announces reimbursement of corporate debt and (NYSE:BIOA)
www.biomedreports.com - January 31 at 4:10 PM
News IconAre Insiders Bumping Up Their Positions in BioAmber Inc. (NYSE:BIOA) - Wall Street Beacon (NYSE:BIOA)
wsbeacon.com - January 30 at 8:47 PM
News IconFree Cash Flow Score in Focus for BioAmber Inc. (NYSE:BIOA) - Gilbert Daily (NYSE:BIOA)
gilbertdaily.com - January 30 at 3:46 PM
News IconHigh Volatility Moving the Needle For Shares of BioAmber Inc. (NYSE:BIOA) - Wall Street Beacon (NYSE:BIOA)
wsbeacon.com - January 30 at 3:46 PM
newswire.ca logoBioAmber announces reimbursement of corporate debt and closing of public offering - Canada NewsWire (press release) (NYSE:BIOA)
www.newswire.ca - January 30 at 3:46 PM
finance.yahoo.com logoBioAmber announces reimbursement of corporate debt and closing of public offering (NYSE:BIOA)
finance.yahoo.com - January 30 at 3:46 PM
News IconTrading Focus: Eye on Shares of Bioamber Inc. (BIOA) - Rives Journal (NYSE:BIOA)
rivesjournal.com - January 29 at 3:52 PM
4-traders.com logoBIOAMBER INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K) (NYSE:BIOA)
www.4-traders.com - January 28 at 2:09 AM
News IconUnorthodox Volume Noted Mid-Session in Shares of BioAmber Inc. (NYSE:BIOA) - Aiken Advocate (NYSE:BIOA)
aikenadvocate.com - January 27 at 3:57 PM
News IconShares Hitting The Skids, Bounding Lower Mid-Day: BioAmber Inc. (NYSE:BIOA) - Wall Street Beacon (NYSE:BIOA)
wsbeacon.com - January 27 at 3:57 PM
News IconBioAmber Inc. increases previously announced public offering to US$17.5 million - PharmiWeb.com (press release) (NYSE:BIOA)
www.pharmiweb.com - January 26 at 4:34 PM
News IconUpdate on Valuation Formula's For BioAmber Inc. (NYSE:BIOA) - Gilbert Daily (NYSE:BIOA)
gilbertdaily.com - January 26 at 4:34 PM
sbwire.com logoWorldwide Succinic Acid Market Set for Rapid Growth, to Reach USD Around 900.1 Million (NYSE:BIOA)
www.sbwire.com - January 25 at 4:24 PM
fxpips.com logoStocks Gapping Down After Hours – AQB, DFBG, BIOA, NK, GLBS, ETRM, OCUL, FSM, RAD (NYSE:BIOA)
www.fxpips.com - January 25 at 4:24 PM
4-traders.com logoBIOAMBER INC. (NYSE:BIOA) Files An 8-K Other Events (NYSE:BIOA)
www.4-traders.com - January 25 at 4:24 PM
4-traders.com logoBIOAMBER INC. : Other Events, Financial Statements and Exhibits (form 8-K) (NYSE:BIOA)
www.4-traders.com - January 25 at 2:30 AM
News IconStock Volatility Review for BioAmber Inc. (NYSE:BIOA) - Gilbert Daily (NYSE:BIOA)
gilbertdaily.com - January 24 at 9:30 PM
finance.yahoo.com logoBioAmber Inc. increases previously announced public offering to US ... - Yahoo Finance (NYSE:BIOA)
finance.yahoo.com - January 24 at 9:30 PM
openpr.com logoGlobal Green & Bio-based Solvents Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 (NYSE:BIOA)
www.openpr.com - January 24 at 4:27 PM
us.rd.yahoo.com logoBioAmber Inc. increases previously announced public offering to US$17.5 million (NYSE:BIOA)
us.rd.yahoo.com - January 24 at 4:27 PM
us.rd.yahoo.com logo7:03 am BioAmber increases the size of previously announced offering of common stock and warrants by 75% for aggregate gross proceeds of $17.5 mln (NYSE:BIOA)
us.rd.yahoo.com - January 24 at 4:27 PM

Social

What is BioAmber's stock symbol?

BioAmber trades on the New York Stock Exchange (NYSE) under the ticker symbol "BIOA."

Where is BioAmber's stock going? Where will BioAmber's stock price be in 2017?

3 brokerages have issued 12-month price objectives for BioAmber's stock. Their forecasts range from $5.50 to $17.00. On average, they expect BioAmber's share price to reach $11.25 in the next year.

When will BioAmber announce their earnings?

BioAmber is scheduled to release their next quarterly earnings announcement on Monday, March, 13th 2017.

Who owns BioAmber stock?

BioAmber's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include FMR LLC (3.90%), Royce & Associates LP (2.86%), Baillie Gifford & Co. (2.01%) and Raymond James Financial Services Advisors Inc. (0.11%). Company insiders that own BioAmber stock include George Frederick John Gosbee, Jean-Francois Huc, Kenneth W Wall, Kurt W Briner, Michael A Hartmann and Raymond J Land.

Who bought BioAmber stock? Who is buying BioAmber stock?

BioAmber's stock was acquired by a variety of institutional investors in the last quarter, including FMR LLC and Royce & Associates LP. Company insiders that have bought BioAmber stock in the last two years include George Frederick John Gosbee, Jean-Francois Huc, Kenneth W Wall, Kurt W Briner, Michael A Hartmann and Raymond J Land.

How do I buy BioAmber stock?

Shares of BioAmber can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of BioAmber stock cost?

One share of BioAmber stock can currently be purchased for approximately $3.41.

BioAmber (NYSE:BIOA) Chart for Thursday, February, 23, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for BioAmber (NYSE:BIOA)

Earnings History Chart

Earnings by Quarter for BioAmber (NYSE:BIOA)

Dividend History Chart

Dividend Payments by Quarter for BioAmber (NYSE:BIOA)

Last Updated on 2/23/2017 by MarketBeat.com Staff